Claudio Ferranti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Claudio Ferranti has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Gianfranco Scaperrotta
Radiologia Senologica, Dipartimento Diagnostica per Immagini e Radioterapia, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
9 shared publications G Coopmans De Yoldi
Divisione di Radiologia Diagnostica B, Istituto Nazionale Tumori, Milano
6 shared publicationsMonica Marchesini
6 shared publicationsG Viganotti
5 shared publicationsLaura Suman
5 shared publicationsS Bergonzi
5 shared publications
Latest Publications
- 8 February 2017
- Published by Elsevier in Academic Radiology
- Vol. 24 (7) , 795-801
How Does the Display Luminance Level Affect Detectability of Breast Microcalcifications and Spiculated Lesions in Digital Breast Tomosynthesis (DBT) Images?
- 8 February 2017
- Published by Elsevier in Academic Radiology
- Vol. 24 (7) , 795-801
How Does the Display Luminance Level Affect Detectability of Breast Microcalcifications and Spiculated Lesions in Digital Breast Tomosynthesis (DBT) Images?
- 1 January 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (1) , 143-149
Performance and role of the breast lesion excision system (BLES) in small clusters of suspicious microcalcifications
- 1 January 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (1) , 143-149
Performance and role of the breast lesion excision system (BLES) in small clusters of suspicious microcalcifications
- 9 October 2015
- Published by SAGE Publications in Tumori Journal
- Vol. 102 (1) , 77-83
Mammographic findings after reshaping with autoprosthesis in women undergoing contralateral breast reconstruction and mastectomy
Aims and background: Breast reduction and mastopexy combined with inferior dermo-lipo-glandular flap (autoprosthesis) gives good breast shape, long-term projection, and upper pole fullness. We assess the impact on breast oncologic surveillance compared to other techniques. Methods: A total of 105 patients who underwent mastectomy and reconstruction were divided into 3 groups of 35 patients each: groups 1 and 2 include patients with contralateral breast symmetrization performed with and without autoprosthesis technique, respectively. Group 3 is a control group without contralateral breast reshaping. On mammography, edema, skin thickening, architectural distortion, and calcifications were recorded, as well as further diagnostic examinations, biopsies, and surgical treatments required. Results: Statistically significant differences (p<0.001) in the first follow-up mammography between groups 1 and 2 were stromal edema (6% vs 51%) and architectural distortion (74% vs 63%). The latest findings meant architectural distortion also have significant difference (p<0.001) in the last mammography (79% vs 66%). Microcalcification has statistically significant difference (p<0.001) in the latest postsurgical mammography, increased in group 1. Skin thickening had a similar course in either group. Mammography follow-up was not impaired in most cases notwithstanding the parenchyma distortion as compared with mammography after breast-conserving surgery. Four core biopsies were performed in both groups: 3 new breast cancers and 1 benign epithelial hyperplasia were found. Conclusions: No difficulties were found impairing mammographic evaluation in patients treated with autoprosthesis as compared to other techniques.
- 9 October 2015
- Published by SAGE Publications in Tumori Journal
- Vol. 102 (1) , 77-83
Mammographic findings after reshaping with autoprosthesis in women undergoing contralateral breast reconstruction and mastectomy
Aims and background: Breast reduction and mastopexy combined with inferior dermo-lipo-glandular flap (autoprosthesis) gives good breast shape, long-term projection, and upper pole fullness. We assess the impact on breast oncologic surveillance compared to other techniques. Methods: A total of 105 patients who underwent mastectomy and reconstruction were divided into 3 groups of 35 patients each: groups 1 and 2 include patients with contralateral breast symmetrization performed with and without autoprosthesis technique, respectively. Group 3 is a control group without contralateral breast reshaping. On mammography, edema, skin thickening, architectural distortion, and calcifications were recorded, as well as further diagnostic examinations, biopsies, and surgical treatments required. Results: Statistically significant differences (p<0.001) in the first follow-up mammography between groups 1 and 2 were stromal edema (6% vs 51%) and architectural distortion (74% vs 63%). The latest findings meant architectural distortion also have significant difference (p<0.001) in the last mammography (79% vs 66%). Microcalcification has statistically significant difference (p<0.001) in the latest postsurgical mammography, increased in group 1. Skin thickening had a similar course in either group. Mammography follow-up was not impaired in most cases notwithstanding the parenchyma distortion as compared with mammography after breast-conserving surgery. Four core biopsies were performed in both groups: 3 new breast cancers and 1 benign epithelial hyperplasia were found. Conclusions: No difficulties were found impairing mammographic evaluation in patients treated with autoprosthesis as compared to other techniques.
- 1 August 2015
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 26 (8) , 1183
Breast Foreign Body Extraction Using the Breast Lesion Excision System
- 1 August 2015
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 26 (8) , 1183
Breast Foreign Body Extraction Using the Breast Lesion Excision System
- 1 September 2012
- Published by Elsevier in European Journal of Radiology
- Vol. 81, S165-S170
What is specific in hereditary breast cancer? High T2 signal intensity as a new semeiotic pattern?
- 1 September 2012
- Published by Elsevier in European Journal of Radiology
- Vol. 81, S165-S170
What is specific in hereditary breast cancer? High T2 signal intensity as a new semeiotic pattern?
- 1 June 2012
- Published by Elsevier in Journal of Ultrasound
- Vol. 15 (2) , 93-98
Has color Doppler a role in the evaluation of mammary lesions?
- 1 June 2012
- Published by Elsevier in Journal of Ultrasound
- Vol. 15 (2) , 93-98
Has color Doppler a role in the evaluation of mammary lesions?
- 20 April 2011
- Published by Elsevier in Journal of Ultrasound
- Vol. 14 (2) , 55-65
Benign breast lesions: Ultrasound
- 20 April 2011
- Published by Elsevier in Journal of Ultrasound
- Vol. 14 (2) , 55-65
Benign breast lesions: Ultrasound
- 4 June 2008
- Published by Springer Nature in European Radiology
- Vol. 18 (11) , 2381-2389
Role of sonoelastography in non-palpable breast lesions
The purpose of this study was to evaluate the diagnostic utility of sonoelastography in differentiating benign from malignant non-palpable breast lesions. A total of 293 BI-RADS 3–5 (Breast Imaging Reporting And Data System) impalpable breast lesions in 278 women was evaluated with B-mode ultrasound (US) and subsequently with sonoelastography (SE) before performing US-guided biopsy. Among the 293 lesions (size up to 2 cm), 110 (37.5%) were histologically malignant and 183 (62.5%) benign. Lesions that were malignant or showed atypical ductal hyperplasia were referred for surgical excision, as well as 32 benign lesions showing discordance between US/SE results and histology. All other benign lesions had US follow-up at 6/12 months, showing stability. Overall performance of SE was lower than US, with sensitivity and specificity of 80% and 80.9%, respectively, for SE as compared with 95.4% and 87.4% for US. Statistical analysis showed no improvement in the joint use of SE and US over the use of US alone, whose performance, however, was very high in our study. SE is a simple, fast and non-invasive diagnostic method that may be a useful aid to US for less experienced radiologists in the assessment of solid non-palpable breast lesions, especially BI-RADS 3, where specificity was higher (88.7%).
- 4 June 2008
- Published by Springer Nature in European Radiology
- Vol. 18 (11) , 2381-2389
Role of sonoelastography in non-palpable breast lesions
The purpose of this study was to evaluate the diagnostic utility of sonoelastography in differentiating benign from malignant non-palpable breast lesions. A total of 293 BI-RADS 3–5 (Breast Imaging Reporting And Data System) impalpable breast lesions in 278 women was evaluated with B-mode ultrasound (US) and subsequently with sonoelastography (SE) before performing US-guided biopsy. Among the 293 lesions (size up to 2 cm), 110 (37.5%) were histologically malignant and 183 (62.5%) benign. Lesions that were malignant or showed atypical ductal hyperplasia were referred for surgical excision, as well as 32 benign lesions showing discordance between US/SE results and histology. All other benign lesions had US follow-up at 6/12 months, showing stability. Overall performance of SE was lower than US, with sensitivity and specificity of 80% and 80.9%, respectively, for SE as compared with 95.4% and 87.4% for US. Statistical analysis showed no improvement in the joint use of SE and US over the use of US alone, whose performance, however, was very high in our study. SE is a simple, fast and non-invasive diagnostic method that may be a useful aid to US for less experienced radiologists in the assessment of solid non-palpable breast lesions, especially BI-RADS 3, where specificity was higher (88.7%).
- Open Access
- 1 November 2006
- Published by SAGE Publications in Tumori Journal
- Vol. 92 (6) , 517-523
MRI in the Early Detection of Breast Cancer in Women with High Genetic Risk
Women with BRCA1 or BRCA2 germline mutations have an elevated risk of developing breast and/or ovarian cancer. Because of the early onset of the disease, screening of this group of women should start at an earlier age than in the general population. The association of breast magnetic resonance imaging (BMRI) and ultrasonography (US) with mammography (MX) and clinical breast examination (CBE) in the regular surveillance of these individuals has been proposed and seems to improve the early detection of breast cancer. Within a multicenter study started by the Istituto Superiore di Sanita (Rome), at the Istituto Nazionale Tumori of Milan (INT) we enrolled 116 women at high genetic risk for breast cancer; they were either BRCA1 or BRCA2 mutation carriers or had a strong family history of breast cancer. They underwent CBE, MX, US and BMRI once a year. Between June 2000 and April 2005, at INT 12 cancers were detected among the 116 screened individuals (10%). In this subgroup, 1 patient refused BMRI and in 2 cases US was not performed. With BMRI we found 11 cancers and 6 of them were detectable only by this technique. In these 6 cases, the size of the disease was less than 1 cm and MX was false negative due to irregularly nodular parenchyma in 4 cases and scar tissue or prosthesis in the other 2. US was not performed in 2 cases and was false negative in 4 cases. Three false positive results were found with BMRI: 1 case was considered suspect but related to hormonal influences; 1 case with the same pattern was sent for second-look US, which gave a negative result and BMRI review after 6 months showed normalization of the parenchyma; in the third case histology revealed the presence of adenosis. No false positive results were registered for MX. The aim of secondary prevention is the detection of cancer at its earliest stage. BMRI screening in women with BRCA1 or BRCA2 mutations or at high familiar risk appears to be highly sensitive and may detect mammographically occult disease. The accuracy of MR imaging is higher than that of conventional imaging but the technique is flawed by a lower specificity. In order to avoid unnecessary biopsies we believe that the combination of BMRI and conventional imaging can be very useful in screening women with a high genetic risk of breast cancer, especially with second-look evaluation by means of US when BMRI yields the only positive diagnostic result. Second-look US has been demonstrated to be of critical importance both in recognizing false positive BMRI results and in guiding biopsies, when necessary.
- 1 November 2006
- Published by SAGE Publications in Tumori Journal
- Vol. 92 (6) , 517-523
Open AccessMRI in the Early Detection of Breast Cancer in Women with High Genetic Risk
Women with BRCA1 or BRCA2 germline mutations have an elevated risk of developing breast and/or ovarian cancer. Because of the early onset of the disease, screening of this group of women should start at an earlier age than in the general population. The association of breast magnetic resonance imaging (BMRI) and ultrasonography (US) with mammography (MX) and clinical breast examination (CBE) in the regular surveillance of these individuals has been proposed and seems to improve the early detection of breast cancer. Within a multicenter study started by the Istituto Superiore di Sanita (Rome), at the Istituto Nazionale Tumori of Milan (INT) we enrolled 116 women at high genetic risk for breast cancer; they were either BRCA1 or BRCA2 mutation carriers or had a strong family history of breast cancer. They underwent CBE, MX, US and BMRI once a year. Between June 2000 and April 2005, at INT 12 cancers were detected among the 116 screened individuals (10%). In this subgroup, 1 patient refused BMRI and in 2 cases US was not performed. With BMRI we found 11 cancers and 6 of them were detectable only by this technique. In these 6 cases, the size of the disease was less than 1 cm and MX was false negative due to irregularly nodular parenchyma in 4 cases and scar tissue or prosthesis in the other 2. US was not performed in 2 cases and was false negative in 4 cases. Three false positive results were found with BMRI: 1 case was considered suspect but related to hormonal influences; 1 case with the same pattern was sent for second-look US, which gave a negative result and BMRI review after 6 months showed normalization of the parenchyma; in the third case histology revealed the presence of adenosis. No false positive results were registered for MX. The aim of secondary prevention is the detection of cancer at its earliest stage. BMRI screening in women with BRCA1 or BRCA2 mutations or at high familiar risk appears to be highly sensitive and may detect mammographically occult disease. The accuracy of MR imaging is higher than that of conventional imaging but the technique is flawed by a lower specificity. In order to avoid unnecessary biopsies we believe that the combination of BMRI and conventional imaging can be very useful in screening women with a high genetic risk of breast cancer, especially with second-look evaluation by means of US when BMRI yields the only positive diagnostic result. Second-look US has been demonstrated to be of critical importance both in recognizing false positive BMRI results and in guiding biopsies, when necessary.